Literature DB >> 11017147

Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.

G S Ashcroft1, K Lei, W Jin, G Longenecker, A B Kulkarni, T Greenwell-Wild, H Hale-Donze, G McGrady, X Y Song, S M Wahl.   

Abstract

Secretory leukocyte protease inhibitor (SLPI) is a serine protease inhibitor with anti-microbial properties found in mucosal fluids. It is expressed during cutaneous wound healing. Impaired healing states are characterized by excessive proteolysis and often bacterial infection, leading to the hypothesis that SLPI may have a role in this process. We have generated mice null for the gene encoding SLPI (Slpi), which show impaired cutaneous wound healing with increased inflammation and elastase activity. The altered inflammatory profile involves enhanced activation of local TGF-beta in Slpi-null mice. We propose that SLPI is a pivotal endogenous factor necessary for optimal wound healing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017147     DOI: 10.1038/80489

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  121 in total

Review 1.  Antimicrobial peptides in periodontal innate defense.

Authors:  Sven-Ulrik Gorr
Journal:  Front Oral Biol       Date:  2011-11-11

Review 2.  Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.

Authors:  Stergios Doumas; Alexandros Kolokotronis; Panagiotis Stefanopoulos
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Expression profiles of elastase1 (NvElastaseI) and secretory leukocyte protease inhibitor (NvSLPI) during forelimb regeneration in adult Notophthalmus viridescens suggest a role in epithelial remodeling and delamination.

Authors:  Sandy Gian Vascotto; Shawn Beug; Richard A Liversage; Catherine Tsilfidis
Journal:  Dev Genes Evol       Date:  2006-03-01       Impact factor: 0.900

4.  Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor.

Authors:  Ole E Sørensen; Dharma R Thapa; K Markus Roupé; Erika V Valore; Ulf Sjöbring; Alice A Roberts; Artur Schmidtchen; Tomas Ganz
Journal:  J Clin Invest       Date:  2006-06-15       Impact factor: 14.808

Review 5.  Gene therapy and wound healing.

Authors:  Sabine A Eming; Thomas Krieg; Jeffrey M Davidson
Journal:  Clin Dermatol       Date:  2007 Jan-Feb       Impact factor: 3.541

6.  Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice.

Authors:  Bettina Hartenstein; Bernd Thilo Dittrich; Dominique Stickens; Babette Heyer; Thiennu H Vu; Sibylle Teurich; Marina Schorpp-Kistner; Zena Werb; Peter Angel
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

7.  Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth.

Authors:  Giada Monami; Velia Emiliozzi; Alessandro Bitto; Francesca Lovat; Shi-Qiong Xu; Silvia Goldoni; Matteo Fassan; Ginette Serrero; Leonard G Gomella; Raffaele Baffa; Renato V Iozzo; Andrea Morrione
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

8.  The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps.

Authors:  Katarzyna Zabieglo; Pawel Majewski; Monika Majchrzak-Gorecka; Agnieszka Wlodarczyk; Beata Grygier; Aneta Zegar; Monika Kapinska-Mrowiecka; Antonina Naskalska; Krzysztof Pyrc; Adam Dubin; Sharon M Wahl; Joanna Cichy
Journal:  J Leukoc Biol       Date:  2015-04-27       Impact factor: 4.962

9.  Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.

Authors:  Nick Devoogdt; Gholamreza Hassanzadeh Ghassabeh; Jing Zhang; Lea Brys; Patrick De Baetselier; Hilde Revets
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

10.  Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin.

Authors:  Kai Kessenbrock; Leopold Fröhlich; Michael Sixt; Tim Lämmermann; Heiko Pfister; Andrew Bateman; Azzaq Belaaouaj; Johannes Ring; Markus Ollert; Reinhard Fässler; Dieter E Jenne
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.